MTFB Motif Bio plc

1.91
-0.34  -15%
Previous Close 2.25
Open 1.97
Price To Book -8.3
Market Cap 28411880
Shares 14,874,551
Volume 388,310
Short Ratio
Av. Daily Volume 854,616

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued February 14, 2019. Noted March 20, 2019 that a meeting is scheduled with the FDA on May 3, 2019. Company will provide an update following receipt of minutes likely 30 days later (est May 31, 2019 with June 2 falling on a weekend).
Iclaprim
Acute bacterial skin and skin structure infections (ABSSSI)
Phase 3 data released April 18, 2017 - primary endpoint of non-inferiority met.
Iclaprim -REVIVE-1
Acute bacterial skin and skin structure infections (ABSSSI)